Validación analítica de una herramienta de investigación para la identificación de variantes asociadas a riesgo cardiovascular.

In order to carry out a more accurate stratification of the cardiovascular risk, Gendiag initiated a project in 2007 with the view to develop a tool for the analysis of certain genetic polymorphisms that have been associated to an increase of the cardiovascular risk.
The project is currently focussed in carrying out the analytical validation of a tool for the identification of more than 300 different genetic biomarkers located in 122 genes associated with cardiovascular risk. These biomarkers have been selected on the basis of the knowledge from Gendiag.exe own R&D and also from Gendiag’s external advisers and in collaboration with the IMIM in Barcelona.
Gendiag.exe has foreseen the development and marketing of a genetic service for cardiovascular risk with the participation of an experts’ committee. The service will integrate the clinical information of the patient with the genetic analysis, in order to generate recommendations directed to the physicians. CeGen Unit from the CNIO will act of reference laboratory during both the development and commercial phase of the service.